Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3F9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,776
Award facts
- Contract value 100% obligated
- $19,776.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,776.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of December 23, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Enbrel, a leading immunosuppressant biologic therapy used primarily in the treatment of rheumatoid arthritis and other autoimmune conditions, represents part of the company's extensive portfolio of specialty medications delivered through the DLA's pharmaceutical supply chain. The SPE2DX contract serves as a flexible procurement vehicle enabling AmerisourceBergen to support multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, across numerous therapeutic domains worldwide.
Quick answers
Who was awarded contract SPE2DR26F3F9E?
SPE2DR26F3F9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F3F9E worth?
The government has obligated $19,776 on SPE2DR26F3F9E.
Is contract SPE2DR26F3F9E an order under another contract?
Yes. SPE2DR26F3F9E is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3F9E competed?
The extent of competition for SPE2DR26F3F9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award